Skip to Main Content

In a wide-ranging and forthcoming interview, Eric Schmidt, the former Google CEO who helped steer the tech giant’s foray into health care, opened up about a host of issues facing the future of medicine.

Among the topics Schmidt touched on in a half-hour conversation at the STAT Health Tech Summit: his upcoming role as the board chair of the powerful Broad Institute, why synthetic biology is a critical field to watch, the fraught debate over patient data privacy and health systems, and why Boston should double down on investing in the life sciences.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!